Ravikirti, Ranjini Roy, Chandrima Pattadar, Rishav Raj, Neeraj Agarwal, Bijit Biswas, . . . Asim Sarfaraz. (2021). Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India. Frontiers Media S.A..
Chicago Style (17th ed.) CitationRavikirti, et al. Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India. Frontiers Media S.A., 2021.
MLA (9th ed.) CitationRavikirti, et al. Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India. Frontiers Media S.A., 2021.
Warning: These citations may not always be 100% accurate.